{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:21Z","timestamp":1786120221027,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/inf.0b013e31820f0f3a","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T11:04:00Z","timestamp":1312887840000},"page":"338-339","source":"Crossref","is-referenced-by-count":11,"title":["Extended-interval Aminoglycoside Dosing in Pediatrics"],"prefix":"10.1097","volume":"30","author":[{"given":"Alice M.","family":"Jenh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita D.","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Milstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/514620","article-title":"The pharmacodynamics....","volume":"27","author":"Lacy","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R2-14-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy....","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"issue":"suppl A","key":"R3-14-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/15.suppl_A.37","article-title":"Postantibiotic effects.","volume":"15","author":"Vogelman","year":"1985","journal-title":"J Antimicrob Chemother"},{"issue":"suppl C","key":"R4-14-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/27.suppl_C.41","article-title":"Influence of dosage schedule on renal cortical accumulation....","volume":"27","author":"De Broe","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R5-14-20210202","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect....","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-14-20210202","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","article-title":"Extended-interval aminoglycoside administration for children.","volume":"114","author":"Contopoulos-Ioannidis","year":"2004","journal-title":"Pediatrics"},{"key":"R7-14-20210202","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI112463","article-title":"Kinetics of gentamicin uptake....","volume":"77","author":"Tran Ba Huy","year":"1986","journal-title":"J Clin Invest"},{"key":"R8-14-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jac\/24.3.281","article-title":"Determinants of efficacy and toxicity of aminoglycosides.","volume":"24","author":"Mattie","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"R9-14-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside.","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-14-20210202","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jac\/28.5.753","article-title":"A prospective randomized study....","volume":"28","author":"Marik","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R11-14-20210202","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/jac\/dkl328","article-title":"Once-daily tobramycin in cystic fibrosis....","volume":"58","author":"Burkhardt","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R12-14-20210202","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1592\/phco.23.1.44.31924","article-title":"Clinical issues surrounding once-daily aminoglycoside.","volume":"23","author":"Knoderer","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R13-14-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1592\/phco.30.1.95","article-title":"Extended-interval once-daily dosing....","volume":"30","author":"Prescott","year":"2010","journal-title":"Pharmacotherapy"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31820f0f3a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:13:36Z","timestamp":1786047216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201104000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31820f0f3a","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}